参考文献/References:
[1] International Organization for Standardization.IS-O 15189:2012,Medical laboratories-requirements for quality and competence[EB/OL].http://www.iso.org/standard/56115.html.
[2] 孔丽蕊,王华丽,吴 风.基于风险管理设计临床生物化学酶类检测项目质量控制策略[J].现代检验医学杂志,2019,34(1):154-156. KONG Lirui,WANG Huali,WU Feng.Quality control strategy of clinical biochemical enzymes detection project based on risk management[J].Journal of Modern Laboratory Medicine,2019,34(1):154-156.
[3] Clinical Laboratory Standards Institute.CLSI C24A3.Statistical qualitycontrol for quantitative measurement procedures:principles and defnitions,4thEdition[S].Wayne:PA,CLSI C24A3,2016.
[4] 曾玉萍,黄亨建.基于风险管理的统计质量控制策略研究进展[J].中华临床实验室管理(电子杂志),2018,6(4):229-233. ZENG Yuping,HUANG Hengjian.Advances of statistical quality controlplan based on risk management[J].Chinese Journal of Clinical Laboratory Management(Electronic Edition),2018,6(4):229-233.
[5] Clinical and Laboratory Standardtions Institute.CLSI EP23-4.Laboratoryquality control hased on risk management; approved quideline[S].Wayne:PA,CLSI EP23-4,2011.
[6] YUNDT-PACHECO J,PARVIN C A.Validating the performance of QC procedures[J].Clin Lab Med,2013,33(1):75-88.
[7] PARVIN C,YUNDT-PACHECO J.System and method for analyzing a QC strategyfor releasing results:United States Patent 8397302[P/OL].2015-01-20,http://www.free patentson line.com /8397302.html.
[8] YAGO M,ALCOVER S.Selecting statistical procedures for quality control planning based on risk management[J].Clin Chem 2016,62(7):959-965.
[9] BAYAT H.Selecting multi-rule quality control procedures based on patient risk[J].Clin Chem Lab Med,2017,55(11):1702-1708.
[10] WESTGARD J O,BAYAT H,WESTGARD S A.Planning risk-based SQC schedules for bracketed operation of continuous production analyzers[J].Clinical Chemistry,2018,64(2):289-296.
相似文献/References:
[1]章晓燕,王 薇,王治国.临床检验正确度控制品-评估偏倚[J].现代检验医学杂志,2016,31(05):147.[doi:10.3969/j.issn.1671-7414.2016.05.044]
ZHANG Xiao-yan,WANG Wei,WANG Zhi-guo.Trueness Controls of Clinical Laboratory to Assess Bias[J].Journal of Modern Laboratory Medicine,2016,31(03):147.[doi:10.3969/j.issn.1671-7414.2016.05.044]
[2]张 莉,蒙立业,杨 培,等.临床检验室内质量控制策略设计新工具-分析批长度Westgard西格玛规则[J].现代检验医学杂志,2019,34(02):137.[doi:10.3969/j.issn.1671-7414.2019.02.035]
ZHANG Li,MENG Li-ye,YANG Pei,et al.New Internal Quality Control Rules Design Toolin Clinical Laboratory -Westgard Sigma Rules with Run Size[J].Journal of Modern Laboratory Medicine,2019,34(03):137.[doi:10.3969/j.issn.1671-7414.2019.02.035]
[3]王 辉,徐克和,唐书强,等.临床生化酶类测定应用保证西格玛与长期缺陷率在统计质量控制策略中的应用[J].现代检验医学杂志,2020,35(01):143.[doi:10.3969/j.issn.1671-7414.2020.01.038]
WANG Hui,XU Ke-he,TANG Shu-qiang,et al.Use of Assured Sigma and Defects Per Million in Statistical Quality Control
Strategies in Clinical Enzymes Measurements[J].Journal of Modern Laboratory Medicine,2020,35(03):143.[doi:10.3969/j.issn.1671-7414.2020.01.038]